New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy.
作者信息
Noorani Tehseen, Martell Jonny
机构信息
Department of Anthropology, Durham University, Durham, United Kingdom.
Centre for Psychedelic Research, Imperial College London, London, United Kingdom.
出版信息
Front Psychiatry. 2021 Sep 10;12:727050. doi: 10.3389/fpsyt.2021.727050. eCollection 2021.
Abstract
摘要
相似文献
1
New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy.
Front Psychiatry. 2021 Sep 10;12:727050. doi: 10.3389/fpsyt.2021.727050. eCollection 2021.
2
Preparing for the Bursting of the Psychedelic Hype Bubble.
JAMA Psychiatry. 2022 Oct 1;79(10):943-944. doi: 10.1001/jamapsychiatry.2022.2546.
3
Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
Psychiatr Serv. 2023 Aug 1;74(8):838-846. doi: 10.1176/appi.ps.20220525. Epub 2023 Mar 29.
4
Prevalence and epidemiological associates of novel psychedelic use in the United States adult population.
J Psychopharmacol. 2019 Sep;33(9):1058-1067. doi: 10.1177/0269881119827796. Epub 2019 Feb 28.
5
Self-blinding citizen science to explore psychedelic microdosing.
Elife. 2021 Mar 2;10:e62878. doi: 10.7554/eLife.62878.
6
United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.
Int J Drug Policy. 2022 Jan;99:103473. doi: 10.1016/j.drugpo.2021.103473. Epub 2021 Oct 6.
7
Psychedelics and Psychotherapy.
Pharmacopsychiatry. 2021 Jul;54(4):167-175. doi: 10.1055/a-1312-7297. Epub 2020 Dec 7.
8
Ethical and legal issues in psychedelic harm reduction and integration therapy.
Harm Reduct J. 2021 Apr 7;18(1):40. doi: 10.1186/s12954-021-00489-1.
10
Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers.
J Psychopharmacol. 2023 Jan;37(1):45-48. doi: 10.1177/02698811221133461. Epub 2022 Nov 15.
引用本文的文献
1
A Systematic Review of Study Design and Placebo Controls in Psychedelic Research.
Psychedelic Med (New Rochelle). 2024 Mar 12;2(1):15-24. doi: 10.1089/psymed.2023.0028. eCollection 2024 Mar.
2
Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience.
BJPsych Open. 2024 Dec 10;10(6):e229. doi: 10.1192/bjo.2024.768.
3
Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol.
Wellcome Open Res. 2025 Apr 22;9:401. doi: 10.12688/wellcomeopenres.22543.1. eCollection 2024.
4
Editorial: Psychedelic humanities.
Front Psychol. 2024 Aug 21;15:1474064. doi: 10.3389/fpsyg.2024.1474064. eCollection 2024.
5
When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.
Neuroethics. 2024;17(1):3. doi: 10.1007/s12152-023-09536-z. Epub 2023 Nov 6.
6
Therapeutic mechanisms of psychedelics and entactogens.
Neuropsychopharmacology. 2024 Jan;49(1):104-118. doi: 10.1038/s41386-023-01666-5. Epub 2023 Jul 24.
7
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors.
J Psychopharmacol. 2023 Jul;37(7):660-678. doi: 10.1177/02698811231155117. Epub 2023 Feb 28.
8
Expectancy in placebo-controlled trials of psychedelics: if so, so what?
Psychopharmacology (Berl). 2022 Oct;239(10):3047-3055. doi: 10.1007/s00213-022-06221-6. Epub 2022 Sep 5.
本文引用的文献
1
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.
Front Pharmacol. 2022 Mar 31;12:788155. doi: 10.3389/fphar.2021.788155. eCollection 2021.
2
Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations.
Transcult Psychiatry. 2022 Oct;59(5):691-704. doi: 10.1177/13634615221082796. Epub 2022 Mar 22.
3
Blinding and expectancy confounds in psychedelic randomized controlled trials.
Expert Rev Clin Pharmacol. 2021 Sep;14(9):1133-1152. doi: 10.1080/17512433.2021.1933434. Epub 2021 Aug 26.
4
Psilocybin: From Serendipity to Credibility?
Front Psychiatry. 2021 Apr 21;12:659044. doi: 10.3389/fpsyt.2021.659044. eCollection 2021.
5
Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?
J Psychopharmacol. 2022 Jan;36(1):6-11. doi: 10.1177/02698811211008567. Epub 2021 Apr 22.
6
The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects.
ACS Pharmacol Transl Sci. 2020 Dec 10;4(2):568-572. doi: 10.1021/acsptsci.0c00194. eCollection 2021 Apr 9.
7
The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects.
ACS Pharmacol Transl Sci. 2020 Dec 10;4(2):563-567. doi: 10.1021/acsptsci.0c00192. eCollection 2021 Apr 9.
8
Trial of Psilocybin versus Escitalopram for Depression.
N Engl J Med. 2021 Apr 15;384(15):1402-1411. doi: 10.1056/NEJMoa2032994.
9
Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy.
Transcult Psychiatry. 2022 Oct;59(5):652-664. doi: 10.1177/1363461520983684. Epub 2021 Jan 26.
10
Antipsychotic Withdrawal Symptoms: A Systematic Review and Meta-Analysis.
Front Psychiatry. 2020 Sep 29;11:569912. doi: 10.3389/fpsyt.2020.569912. eCollection 2020.
Zotero 插件